Picrasidine I

Picrasidine I
Product Name Picrasidine I
CAS No.: 100234-59-1
Catalog No.: CFN99019
Molecular Formula: C14H12N2O2
Molecular Weight: 240.3 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Yellow powder
Targets: MAPK | NF-κB | ROS | c-Fos | NFATc1
Source: The barks of Picrasma quassioides.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $368/5mg
Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, NF-κB and ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Sci Rep.2015, 5:13194
  • Int J Mol Sci.2018, 19(9):E2825
  • Sci Rep. 2018, 462(8)
  • Molecules.2018, 23(2)
  • J Cell Mol Med.2018, 22(9):4236-4242
  • Int J Mol Med.2016, 37(2):501-8
  • J of the Korean Society of Cosmetics and Cosmetology2019, 225-231
  • Pharmaceutical Chemistry Journal2019, 52(12):986-991
  • Food Research International2016, 106-113
  • Front Neurosci.2019, 13:1091
  • Crenatine

    Catalog No: CFN98313
    CAS No: 26585-14-8
    Price: Inquiry(manager@chemfaces.com)
    Picrasidine I

    Catalog No: CFN99019
    CAS No: 100234-59-1
    Price: $368/5mg
    Picrasidine J

    Catalog No: CFN99020
    CAS No: 100234-62-6
    Price: Inquiry(manager@chemfaces.com)
    Dehydrocrenatidine

    Catalog No: CFN97116
    CAS No: 65236-62-6
    Price: Inquiry(manager@chemfaces.com)
    1-Acetyl-beta-carboline

    Catalog No: CFN92122
    CAS No: 50892-83-6
    Price: Inquiry(manager@chemfaces.com)
    1-Methoxycarbonyl-beta-carboline

    Catalog No: CFN98456
    CAS No: 3464-66-2
    Price: $288/5mg
    1-Methoxycarbonyl-beta-carboline-N-oxide

    Catalog No: CFN95023
    CAS No: 74690-74-7
    Price: $413/5mg
    1-Ethoxycarbonyl-beta-carboline

    Catalog No: CFN92123
    CAS No: 72755-19-2
    Price: Inquiry(manager@chemfaces.com)
    4-Hydroxy-1-methoxycarbonyl-beta-carboline

    Catalog No: CFN92929
    CAS No: 74690-72-5
    Price: Inquiry(manager@chemfaces.com)
    4-Methoxy-1-methoxycarbonyl-beta-carboline

    Catalog No: CFN97037
    CAS No: 60807-25-2
    Price: Inquiry(manager@chemfaces.com)
    Cellular Physiology & Biochemistry, 2017:1425-1435.
    Picrasidine I from Picrasma Quassioides Suppresses Osteoclastogenesis via Inhibition of RANKL Induced Signaling Pathways and Attenuation of ROS Production.[Reference: WebLink]
    Osteoporosis is a metabolic bone disorder that tortures about millions of people worldwide. Recent study demonstrated agents derived from picrasma quassioides is a promising drug for targets multiple signaling pathways. However its potential in treatment of bone loss has not been fully understood.
    METHODS AND RESULTS:
    The bone marrow macrophages (BMMs) were cultured and induced with M-CSF and RANKL followed by Picrasidine I (PI) treatment. Then the effects of PI on osteoclast formation were evaluated by counting tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells. Moreover, effects of PI on bone resorption activity of mature osteoclast were studied through bone resorption pit counting and actin ring structure analysis. Further, the involved potential signaling pathways cross-talking were investigated by performed Western blotting and quantitative real-time PCR examination. Results demonstrated PI strongly inhibited RANKL induced osteoclast formation from its precursors. Mechanistically, the inhibitory effect of PI on osteoclast differentiation was due to the suppression of osteoclastogenic transcription factors, c-Fos and NFATc1. Moreover, PI markedly blocked the RANKL-induced osteoclastogenesis by attenuating MAPKs and NF-κB signaling pathways. In addition, PI decreased the ROS generation in osteoclast and osteoblast.
    CONCLUSIONS:
    Taken together our data demonstrate that PI has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, NF-κB and ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.
    Pinoresinol 4-O-beta-D-glucopyranoside

    Catalog No: CFN97180
    CAS No: 69251-96-3
    Price: $298/20mg
    Zederone

    Catalog No: CFN92616
    CAS No: 7727-79-9
    Price: $278/20mg
    Tubuloside A

    Catalog No: CFN90669
    CAS No: 112516-05-9
    Price: $218/20mg
    Apterin

    Catalog No: CFN95005
    CAS No: 53947-89-0
    Price: $388/10mg
    Monomethyl lithospermate

    Catalog No: CFN91005
    CAS No: 933054-33-2
    Price: $333/10mg
    Cassiaside C

    Catalog No: CFN95120
    CAS No: 119170-52-4
    Price: $318/10mg
    Emodin-8-O-beta-gentiobioside

    Catalog No: CFN95132
    CAS No: 66466-22-6
    Price: $368/5mg
    Patulitrin

    Catalog No: CFN95153
    CAS No: 19833-25-1
    Price: $398/5mg
    (E)-6-O-(p-coumaroyl)scandoside methyl ester

    Catalog No: CFN95192
    CAS No: 83946-90-1
    Price: $218/10mg
    Spinacetin

    Catalog No: CFN95194
    CAS No: 3153-83-1
    Price: $318/5mg